Glucose Health Inc Financials
This page shows Glucose Health Inc (GLUC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Glucose Health Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Glucose Health Inc generates $0.10 in operating cash flow (-$39K OCF vs -$410K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Glucose Health Inc earns $-0.3 in operating income for every $1 of interest expense (-$87K vs $324K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Glucose Health Inc generated $313K in revenue in fiscal year 2016. This represents an increase of 7232.1% from the prior year.
Glucose Health Inc reported -$410K in net income in fiscal year 2016. This represents a decrease of 54.3% from the prior year.
Cash & Balance Sheet
Glucose Health Inc held $21K in cash against $0 in long-term debt as of fiscal year 2016.
Glucose Health Inc had 3M shares outstanding in fiscal year 2016. This represents an increase of 50.5% from the prior year.
Margins & Returns
Glucose Health Inc's gross margin was 6.1% in fiscal year 2016, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.
Glucose Health Inc's operating margin was -27.7% in fiscal year 2016, reflecting core business profitability. This is up 3628.1 percentage points from the prior year.
Glucose Health Inc's net profit margin was -131.0% in fiscal year 2016, showing the share of revenue converted to profit. This is up 6097.1 percentage points from the prior year.
Capital Allocation
GLUC Income Statement
| Metric | Q3'17 | Q2'17 | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24K-30.1% | $34K+125.3% | $15K-0.5% | $15K+619.9% | $2K-99.3% | $296K+246407.5% | $120-92.7% | $2K |
| Cost of Revenue | $790+190.4% | $272-98.1% | $15K-1.1% | $15K+212.7% | $5K-98.3% | $274K+457340.0% | $60 | N/A |
| Gross Profit | $23K-31.9% | $34K+7040.4% | $473+22.5% | $386+114.7% | -$3K-112.3% | $21K+35475.0% | $60+9.1% | $55 |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $5K-37.9% | $8K-39.5% | $12K+83.7% | $7K-81.3% | $36K+530.4% | $6K+97.7% | $3K-96.3% | $79K |
| Operating Income | $5K-71.2% | $16K+156.8% | -$28K-13.9% | -$25K+55.3% | -$56K-1021.0% | $6K+149.1% | -$12K+17.7% | -$15K |
| Interest Expense | $6K+12.2% | $5K+632.2% | $696-99.4% | $108K+2.7% | $105K+12.7% | $93K+449.8% | $17K-20.8% | $21K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $19K-61.9% | $49K+269.8% | -$29K+78.2% | -$133K+17.3% | -$161K-84.1% | -$87K-198.6% | -$29K+37.5% | -$47K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GLUC Balance Sheet
| Metric | Q3'17 | Q2'17 | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26K-3.5% | $27K+44.8% | $19K-43.1% | $33K-24.6% | $44K-78.8% | $207K+301.1% | $52K+235.1% | $15K |
| Current Assets | $26K-3.5% | $27K+45.4% | $19K-43.4% | $33K-24.6% | $44K-78.9% | $207K+302.9% | $51K+239.8% | $15K |
| Cash & Equivalents | $17K-9.2% | $18K+103.3% | $9K-56.1% | $21K-13.1% | $24K-14.9% | $28K+1327.2% | $2K-5.3% | $2K |
| Inventory | $0 | $0 | $0 | N/A | $6K-22.8% | $8K0.0% | $8K-0.7% | $8K |
| Accounts Receivable | $9K+3.5% | $9K-8.7% | $10K-17.8% | $12K-0.2% | $12K-93.0% | $168K+5244.3% | $3K0.0% | $3K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $453K-5.0% | $477K-12.1% | $542K+2.6% | $529K+26.6% | $418K-1.5% | $424K-6.8% | $455K+12.8% | $403K |
| Current Liabilities | $453K-5.0% | $477K-12.1% | $542K+2.6% | $529K+26.6% | $418K-1.5% | $424K-6.8% | $455K+12.8% | $403K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$426K+5.1% | -$449K+14.2% | -$524K-5.7% | -$495K-32.6% | -$374K-72.4% | -$217K+46.2% | -$403K-3.9% | -$388K |
| Retained Earnings | -$6.2M+0.3% | -$6.2M+0.8% | -$6.3M-0.5% | -$6.2M-2.0% | -$6.1M-2.7% | -$6.0M-1.6% | -$5.9M-0.5% | -$5.8M |
GLUC Cash Flow Statement
| Metric | Q3'17 | Q2'17 | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2K-141.3% | -$695+94.0% | -$12K-244.6% | -$3K-105.4% | $62K+225.8% | -$49K-1.2% | -$49K-426.1% | -$9K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Financing Cash Flow | $0 | N/A | N/A | $0+100.0% | -$66K-188.0% | $75K+54.6% | $49K+1840.0% | $3K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GLUC Financial Ratios
| Metric | Q3'17 | Q2'17 | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 96.7%-2.5pp | 99.2%+96.1pp | 3.1%+0.6pp | 2.5%+126.9pp | -124.4%-131.6pp | 7.2%-42.8pp | 50.0%+46.7pp | 3.4% |
| Operating Margin | 19.5%-27.7pp | 47.2%+234.6pp | -187.4%-23.8pp | -163.6%+2469.4pp | -2633.0%-2635.0pp | 2.0%+10231.2pp | -10229.2%-9319.9pp | -909.3% |
| Net Margin | 78.9%-65.8pp | 144.7%+336.7pp | -192.0%+683.6pp | -875.5%+6746.2pp | -7621.8%-7592.2pp | -29.5%+24356.3pp | -24385.8%-21532.4pp | -2853.5% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 71.2%-109.1pp | 180.3%+334.1pp | -153.8%+247.5pp | -401.2%-35.4pp | -365.8%-323.6pp | -42.2%+14.5pp | -56.7%+247.1pp | -303.7% |
| Current Ratio | 0.060.0 | 0.06+0.0 | 0.03-0.0 | 0.06-0.0 | 0.10-0.4 | 0.49+0.4 | 0.11+0.1 | 0.04 |
| Debt-to-Equity | -1.060.0 | -1.06-0.0 | -1.04+0.0 | -1.07+0.1 | -1.12+0.8 | -1.96-0.8 | -1.13-0.1 | -1.04 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$495K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Glucose Health Inc's annual revenue?
Glucose Health Inc (GLUC) reported $313K in total revenue for fiscal year 2016. This represents a 7232.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Glucose Health Inc's revenue growing?
Glucose Health Inc (GLUC) revenue grew by 7232.1% year-over-year, from $4K to $313K in fiscal year 2016.
Is Glucose Health Inc profitable?
No, Glucose Health Inc (GLUC) reported a net income of -$410K in fiscal year 2016, with a net profit margin of -131.0%.
What is Glucose Health Inc's gross margin?
Glucose Health Inc (GLUC) had a gross margin of 6.1% in fiscal year 2016, indicating the percentage of revenue retained after direct costs of goods sold.
What is Glucose Health Inc's operating margin?
Glucose Health Inc (GLUC) had an operating margin of -27.7% in fiscal year 2016, reflecting the profitability of core business operations before interest and taxes.
What is Glucose Health Inc's net profit margin?
Glucose Health Inc (GLUC) had a net profit margin of -131.0% in fiscal year 2016, representing the share of revenue converted into profit after all expenses.
What is Glucose Health Inc's operating cash flow?
Glucose Health Inc (GLUC) generated -$39K in operating cash flow during fiscal year 2016, representing cash generated from core business activities.
What are Glucose Health Inc's total assets?
Glucose Health Inc (GLUC) had $33K in total assets as of fiscal year 2016, including both current and long-term assets.
What is Glucose Health Inc's current ratio?
Glucose Health Inc (GLUC) had a current ratio of 0.06 as of fiscal year 2016, which is below 1.0, which may suggest potential liquidity concerns.
What is Glucose Health Inc's debt-to-equity ratio?
Glucose Health Inc (GLUC) had a debt-to-equity ratio of -1.07 as of fiscal year 2016, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Glucose Health Inc's return on assets (ROA)?
Glucose Health Inc (GLUC) had a return on assets of -1238.3% for fiscal year 2016, measuring how efficiently the company uses its assets to generate profit.
What is Glucose Health Inc's cash runway?
Based on fiscal year 2016 data, Glucose Health Inc (GLUC) had $21K in cash against an annual operating cash burn of $39K. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Glucose Health Inc's debt-to-equity ratio negative or unusual?
Glucose Health Inc (GLUC) has negative shareholder equity of -$495K as of fiscal year 2016, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Glucose Health Inc's Piotroski F-Score?
Glucose Health Inc (GLUC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Glucose Health Inc's earnings high quality?
Glucose Health Inc (GLUC) has an earnings quality ratio of 0.10x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Glucose Health Inc cover its interest payments?
Glucose Health Inc (GLUC) has an interest coverage ratio of -0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.